177 related articles for article (PubMed ID: 233917)
1. Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics.
Shiku H; Takahashi T; Resnick LA; Oettgen HF; Old LJ
J Exp Med; 1977 Mar; 145(3):784-9. PubMed ID: 233917
[TBL] [Abstract][Full Text] [Related]
2. Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.
Real FX; Mattes MJ; Houghton AN; Oettgen HF; Lloyd KO; Old LJ
J Exp Med; 1984 Oct; 160(4):1219-33. PubMed ID: 6237165
[TBL] [Abstract][Full Text] [Related]
3. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.
Carey TE; Takahashi T; Resnick LA; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3278-82. PubMed ID: 1067619
[TBL] [Abstract][Full Text] [Related]
4. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
Plain MJ; Whitehead RH; Jose DG
Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of monoclonal antibodies against human malignant melanoma.
Herlyn M; Steplewski Z; Herlyn D; Clark WH; Ross AH; Blaszczyk M; Pak KY; Koprowski H
Cancer Invest; 1983; 1(3):215-24. PubMed ID: 6667406
[TBL] [Abstract][Full Text] [Related]
6. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.
Houghton AN; Taormina MC; Ikeda H; Watanabe T; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4260-4. PubMed ID: 6933476
[TBL] [Abstract][Full Text] [Related]
7. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.
Shiku H; Takahashi T; Oettgen HF
J Exp Med; 1976 Oct; 144(4):873-81. PubMed ID: 978138
[TBL] [Abstract][Full Text] [Related]
8. Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
Usener D; Gerhardt A; Schadendorf D; Eichmüller S
Br J Dermatol; 2003 Aug; 149(2):282-8. PubMed ID: 12932233
[TBL] [Abstract][Full Text] [Related]
9. Cell surface antigens of human renal cancer defined by autologous typing.
Ueda R; Shiku H; Pfreundschuh M; Takahashi T; Li LT; Whitmore WF; Oettgen HF; Old LJ
J Exp Med; 1979 Sep; 150(3):564-79. PubMed ID: 479762
[TBL] [Abstract][Full Text] [Related]
10. Autologous antibodies to meningioma cell surface antigens.
Pfreundschuh M; Röhrich M; Piotrowksi W; Penzholz H; Fischer H
Anticancer Res; 1981; 1(6):367-72. PubMed ID: 6284017
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens.
Albino AP; Lloyd KO; Houghton AN; Oettgen HF; Old LJ
J Exp Med; 1981 Dec; 154(6):1764-78. PubMed ID: 6976407
[TBL] [Abstract][Full Text] [Related]
12. Serological analysis of cell surface antigens of malignant human brain tumors.
Pfreundschuh M; Shiku H; Takahashi T; Ueda R; Ransohoff J; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5122-6. PubMed ID: 283420
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum.
Kirkwood JM; Vlock DR
Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327
[TBL] [Abstract][Full Text] [Related]
14. Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells.
Herlyn M; Clark WH; Mastrangelo MJ; Guerry DP; Elder DE; LaRossa D; Hamilton R; Bondi E; Tuthill R; Steplewski Z; Koprowski H
Cancer Res; 1980 Oct; 40(10):3602-9. PubMed ID: 6159966
[TBL] [Abstract][Full Text] [Related]
15. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.
Dippold WG; Lloyd KO; Li LT; Ikeda H; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6114-8. PubMed ID: 6934537
[TBL] [Abstract][Full Text] [Related]
16. Identification of melanoma antigens that are immunogenic in humans and expressed in vivo.
Applebaum J; Reynolds S; Knispel J; Oratz R; Shapiro R; Bystryn JC
J Natl Cancer Inst; 1998 Jan; 90(2):146-9. PubMed ID: 9450575
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer-testis antigens.
Beeton-Kempen N; Duarte J; Shoko A; Serufuri JM; John T; Cebon J; Blackburn J
Int J Cancer; 2014 Oct; 135(8):1842-51. PubMed ID: 24604332
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
Saxton RE; Mann BD; Morton DL; Burk MW
Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
[TBL] [Abstract][Full Text] [Related]
19. Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells.
Seibert E; Sorg C; Happle R; Macher E
Int J Cancer; 1977 Feb; 19(2):172-8. PubMed ID: 402317
[TBL] [Abstract][Full Text] [Related]
20. Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells.
Ehlken H; Schadendorf D; Eichmüller S
Int J Cancer; 2004 Jan; 108(2):307-13. PubMed ID: 14639620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
